A(2A) adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis.
暂无分享,去创建一个
D. Tuscano | M. Trincavelli | C. Martini | V. Gremigni | A. Lucacchini | B. Costa | B. Chelli | A. Falleni
[1] K. Jacobson,et al. Adenosine-induced cell death: evidence for receptor-mediated signalling , 1999, Apoptosis.
[2] K. Klotz,et al. Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. , 2002, The Journal of investigative dermatology.
[3] Neal Castagnoli,et al. 8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism* , 2002, The Journal of Biological Chemistry.
[4] D. Tuscano,et al. Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells. , 2002, Biochemical pharmacology.
[5] Y. Yoo,et al. Role of p38 MAPK in the regulation of apoptosis signaling induced by TNF-alpha in differentiated PC12 cells. , 2002, Journal of biochemistry and molecular biology.
[6] T. Stone,et al. Enhanced neuronal damage by co‐administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists , 2002, British journal of pharmacology.
[7] M. Falchi,et al. Blockade of Striatal Adenosine A2A Receptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum , 2002, The Journal of Neuroscience.
[8] J. Losy,et al. Early TNF‐α levels correlate with ischaemic stroke severity , 2001 .
[9] B. Cronstein,et al. Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.
[10] R. Cunha,et al. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors , 2001, Neurochemistry International.
[11] E. Ongini,et al. Adenosine receptors in neurological disorders , 2000 .
[12] E. Deitch,et al. Adenosine inhibits IL-12 and TNF-a production via adenosine A 2 a receptor-dependent and independent mechanisms , 2000 .
[13] K. Jeng,et al. Induction of cytokine genes and IL-1α by chemical hypoxia in PC12 cells , 2000 .
[14] M. Sitkovsky,et al. Study of A2A adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A2A receptor‐unrelated lymphotoxicity , 2000, British journal of pharmacology.
[15] F. Pedata,et al. Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats , 2000, Neuroreport.
[16] M. Sitkovsky,et al. A2A receptor dependent and A2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency , 2000 .
[17] K. Jacobson,et al. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. , 2000, Experimental cell research.
[18] J. Bockaert,et al. “Inflammatory” Cytokines , 2000, Journal of neurochemistry.
[19] G. Chrousos,et al. Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.
[20] R. Dantzer,et al. Cytokine signals propagate through the brain , 2000, Molecular Psychiatry.
[21] F. Cattabeni,et al. Brain Adenosine Receptors as Targets for Therapeutic Intervention in Neurodegenerative Diseases , 1999, Annals of the New York Academy of Sciences.
[22] M. Moskowitz,et al. A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice , 1999, The Journal of Neuroscience.
[23] P. Popoli,et al. The intrastratial injection of an adenosine A2 receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease , 1999, Brain Research.
[24] F. Pedata,et al. Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. , 1999, Neuroreport.
[25] N. Rothwell. Cytokines ‐ killers in the brain? , 1999 .
[26] B. Fredholm,et al. Signaling via A2A adenosine receptor in four PC12 cell clones , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] E. Ongini,et al. Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats , 1998, Neuroreport.
[28] T. Stone,et al. Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist , 1998, Brain Research.
[29] M. Weller,et al. Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide , 1998 .
[30] B. Cacciari,et al. Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors. , 1998, Life sciences.
[31] C. Franceschi,et al. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells , 1998, Neurochemistry International.
[32] T. Stone,et al. Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists , 1998, Neuroscience.
[33] D. Millhorn,et al. Hypoxia regulates the cAMP- and Ca2+/calmodulin signaling systems in PC12 cells. , 1998, Biochemical and biophysical research communications.
[34] B. Fredholm,et al. Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[35] E. Ongini,et al. Adenosine A2A Receptors and Neuroprotection , 1997, Annals of the New York Academy of Sciences.
[36] Sergi Ferré,et al. Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.
[37] Markus Schwaninger,et al. Stimulation of Interleukin‐6 Secretion and Gene Transcription in Primary Astrocytes by Adenosine , 1997, Journal of neurochemistry.
[38] B. Fredholm,et al. Neonatal cerebral hypoxia-ischemia: The effect of adenosine receptor antagonists , 1997, Neuropharmacology.
[39] Y. Chern,et al. Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response* , 1997, The Journal of Biological Chemistry.
[40] E. Ongini,et al. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. , 1996, The Journal of pharmacology and experimental therapeutics.
[41] P. Popoli,et al. Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. , 1995, European journal of pharmacology.
[42] G Burnstock,et al. Nomenclature and Classification of Purinoceptors* , 2005 .
[43] J. Phillis,et al. CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. , 1994, Life sciences.
[44] Y. Chern,et al. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. , 1993, Molecular pharmacology.